Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Shares Sold by Fmr LLC

Fmr LLC trimmed its stake in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) by 9.1% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 663,600 shares of the company’s stock after selling 66,239 shares during the quarter. Fmr LLC owned approximately 0.32% of Fidelity Disruptive Medicine ETF worth $17,446,000 at the end of the most recent quarter.

Separately, Wealth Enhancement Advisory Services LLC raised its holdings in shares of Fidelity Disruptive Medicine ETF by 3.7% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 539,827 shares of the company’s stock worth $14,192,000 after acquiring an additional 19,240 shares during the last quarter.

Fidelity Disruptive Medicine ETF Stock Down 0.1 %

NASDAQ FMED opened at $26.23 on Wednesday. Fidelity Disruptive Medicine ETF has a fifty-two week low of $21.88 and a fifty-two week high of $26.68. The stock has a market cap of $55.08 million, a price-to-earnings ratio of 35.73 and a beta of 0.94. The business has a fifty day moving average of $25.91 and a 200-day moving average of $25.23.

Fidelity Disruptive Medicine ETF Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.